TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| When Winning Isn't Everything Amid ever-rising calls for more exercise there isn't much guidance on cutting back, and as baby boomers enter their 50s and 60s, their competitiveness can become a threat to their health. sec.online.wsj.com |
Abbot in Bidding for Solvay Drug Unit Abbott has emerged as a strong competitor to purchase the pharmaceutical unit of Belgian conglomerate Solvay, setting up a potential showdown with rival bidder Nycomed. online.barrons.com |
Pfizer Profit Jumps Despite Drop in Sales Pfizer's profit rose 26% in the absence of a year-earlier charge. Sales fell 2.9%, hurt by competition from generic drugs and unfavorable currency rates. online.wsj.com |
Sanofi-Aventis to Establish Venture Capital Fund, Looking for 'Right Brain Activity' The Burrill Report submits: By Marie DaghlianChris Viehbacher, CEO of Sanofi-Aventis (SNY), said his company will establish a venture capital fund, joining an ever-growing queue of pharma venture capital funds seeking to gain better access biotech innovation. Viehbacher confirmed the French drugmaker’s plans in comments made at an event at Sanofi’s R&D campus in Cambridge, Massachusetts, the online publication Xconomy reported. The company also announced a significant expansion and extension of its collaboration with Regeneron Pharmaceuticals (REGN). The deal comes a month after Sanofi-Aventis struck a partnership deal with Merrimack Pharmaceuticals focused on the biotech's experimental antibody drug for cancer, and continues Sanofi's strategy of looking outside the company for what Viehbacher calls "right brain activity" that leads to creativity and innovation.Complete Story » seekingalpha.com |
Hospital, Insurer Stocks Perk Up Health-care stocks are enjoying gains this week, with traders breathing a sigh of relief that Washington's debate over an industry overhaul is nearing an end. online.wsj.com |